Cancer Immunotherapies
                                                                                    
Category
Format
  • Video
Credits
  • Participation
An Introduction to Immuno-Safety Science
                                                                                    
Category
Format
  • Video
Credits
  • Participation
Overview of Cancer Immunotherapies
Welcome to the HESI ITC On-demand training course. We are delighted that you have chosen to enhance your  educational journey in immuno-safety science by enrolling in this  course. The "Overview of Cancer Immunotherapies" course  is 1 of 10 courses included in the Cancer Immuno
Category
Format
Credits
  • Participation
Cytokine Release Syndrome
The "Cytokine Release " course  is 1 of 10 courses included in the Cancer Immunotherapies Module  and is led by Dr. Madeline Fort, PhD- at  Amgen
Category
Format
Credits
Assessing Risk of Adverse Pregnancy Outcomes for Immuno-Oncology Programs
The "Assessing Risk of Adverse Pregnancy Outcomes for Immuno-Oncology Programs" is 1 of 10 courses included in the Cancer Immunotherapies module. This course is led by
Category
Format
Credits
Nonclinical Safety assessment of therapies targeting neoantigens
The "Nonclinical Safety assessment of therapies targeting neoantigens" is 1 of 10 courses included in the Cancer Immunotherapies module. This course is led by Dr. Gautham Rao at Genentech 
Category
Format
  • Video
Credits
  • Participation
Quantitative systems pharmacology/ toxicology modeling for IO therapies
The "Quantitative systems pharmacology /toxicology modeling for IO therapies" is 1 of 10 courses included in the Cancer Immunotherapies module. This course is led by Dr. Roy song at Glaxo Smith Kline
Category
Format
Credits
Neurotoxicity across Cancer Modalities
The "Neurotoxicity across Cancer Modalities" course is 1 of 10 courses included in the Cancer Immunotherapies module. This course is led by Dr. Juliane Gust, MD at Seattle Children Hospital
Category
Format
Credits
Regulatory Considerations for Cancer Immunotherapies:​ Preclinical Focus​
The "Regulatory Considerations for Cancer Immunotherapies:​ Preclinical Focus​" course is one of 18 course in the Introduction to Immuno- Safety Science.  This course is led by Dr. Mary Ellen Cosenza, Ph.D. DABT, ERT, RAC, ATS​ - at Toxicology consulting.
Category
Format
Credits
Natural Killer Cells and their use for Cancer Immunotherapy
The "Natural Killer Cells and their for Cancer Immunotherapy " course  is 1 of 10 courses included in the Cancer Immunotherapies Module  and is led by Dr.  Alexandre Iannello - at Sonoma Biotherapeutics
Category
Format
Credits

Pages